August 2026
1. SLIPCZUK L
   How do we move beyond one-size-fits-all in cardiovascular care?
   Prog Cardiovasc Dis. 2026 Aug 7:S0033-0620(26)00074.
   

   >> Share

   
   July 2026
2. DUAN MJ, Poelman MP, Corpeleijn E, Biesbroek S, et al
   Socioeconomic inequalities in the association between diet quality and incident cardiovascular diseases: A prospective study in the Netherlands.
   Prog Cardiovasc Dis. 2026 Jul 6:S0033-0620(26)00068.
   

   >> Share

   
   June 2026
3. KOO BK
   COVID-19 and coronary atherosclerosis: Unmasking and accelerating?
   Prog Cardiovasc Dis. 2026 Jun 24:S0033-0620(26)00064.
   

   >> Share

   
   May 2026
4. MARKOUSIS-MAVROGENIS G, Ebrahimihoor E, Lima JAC, Weber B, et al
   Coronary artery Ectatic/Aneurysmatic disease: From pathophysiology to management.
   Prog Cardiovasc Dis. 2026 May 23:S0033-0620(26)00044.
   

   >> Share

   
   
5. MCPARLAND J, Rikhi R, Bhatia HS, Razavi AC, et al
   Comparative associations of LDL-C, Lp(a), hsCRP, and IL-6 with cardiovascular risk: Insights from the United Kingdom (UK) biobank and the multi-ethnic study of atherosclerosis (MESA).
   Prog Cardiovasc Dis. 2026 May 22:S0033-0620(26)00046.
   

   >> Share

   
   
6. SLIPCZUK L
   Integrating structure, data, and prevention in modern cardiovascular care.
   Prog Cardiovasc Dis. 2026 May 20:S0033-0620(26)00045.
   

   >> Share

   
   
7. SOROA M, Filimonov AK, van Rosendael SE, Dakroub A, et al
   The impact of Corona virus disease - 2019 on coronary atherosclerosis: Rationale and design of the COrona VIrus Disease-2019 computed tomography (COVID-CT) registry.
   Prog Cardiovasc Dis. 2026 May 2:S0033-0620(26)00035.
   

   >> Share

   
   April 2026
8. KAZIBWE R, Schaich CL, Kingsley JA, Chevli P, et al
   Lipoprotein(a), remnant cholesterol, and high-sensitivity C-reactive protein as complementary biomarkers for myocardial infarction risk assessment.
   Prog Cardiovasc Dis. 2026 Apr 30:S0033-0620(26)00041.
   

   >> Share

   
   
9. SHAIK A, Bhatt DL
   The cost of missing cardiovascular data in South Asia and the promise of lifecard.
   Prog Cardiovasc Dis. 2026 Apr 29:S0033-0620(26)00038.
   

   >> Share

   
   
10. CIPOLLETTA E, Moroncini G
    Gout as a cardiovascular risk factor: Implications beyond the joint.
    Prog Cardiovasc Dis. 2026 Apr 21:S0033-0620(26)00036.
    

    >> Share

    
    March 2026
11. KHAN S, Karim S, Somers VK
    Beyond duration: The emerging role of sleep architecture in cardiovascular risk prediction.
    Prog Cardiovasc Dis. 2026 Mar 26:S0033-0620(26)00027.
    

    >> Share

    
    
12. KANG J, Kim HJ, Yim Y, Kim MS, et al
    Wearable-derived REM sleep as a modifiable risk factor for cardiovascular disease: A multimodal prediction model in the All of Us Research Program.
    Prog Cardiovasc Dis. 2026 Mar 4:S0033-0620(26)00014.
    

    >> Share

    
    
13. VADALA G, Mashayekhi K, Madaudo C, Behnes M, et al
    Revascularization of patients with chronic total occlusion and left ventricular systolic dysfunction.
    Prog Cardiovasc Dis. 2026;95:92-106.
    

    >> Share

    
    
14. PARK JR, Bae JS, Lee JM, Cho YH, et al
    Incremental prognostic value of coronary CTA after treadmill testing in noncardiac surgery candidates: Results from a multicenter prospective cohort.
    Prog Cardiovasc Dis. 2026;95:66-73.
    

    >> Share

    
    
15. TYAGI M, Prabhakar AP, Kalra DK
    Arterial calcification as an imaging biomarker of the risk of stroke, dementia, and cognitive decline.
    Prog Cardiovasc Dis. 2026;95:119-128.
    

    >> Share

    
    February 2026
16. PEI H, He L, Wang S, Mo C, et al
    Association between gout and cardiovascular disease: A register-based cohort study.
    Prog Cardiovasc Dis. 2026 Feb 16:S0033-0620(26)00008.
    

    >> Share

    
    January 2026
17. SHEIKH S, Khoja A, Naeem U, Fayyaz M, et al
    Longitudinal study of cardiovascular-kidney-metabolic syndrome risk assessment among adolescents and young adults (10-45 years) in Pakistan (LIFECARD): Study design and methodology.
    Prog Cardiovasc Dis. 2026 Jan 20:S0033-0620(26)00005.
    

    >> Share

    
    
18. BIELINSKI SJ, St Sauver JL, Borlaug BA
    Visceral adiposity tissue: A promising biomarker to improve cardiovascular disease risk assessment.
    Prog Cardiovasc Dis. 2026 Jan 17:S0033-0620(26)00003.
    

    >> Share

    
    
19. SAVO MT, Pergola V, De Amicis M, Cozac DA, et al
    Computed tomography-derived score as a predictor of major adverse cardiovascular events in patients with severe aortic stenosis.
    Prog Cardiovasc Dis. 2026 Jan 14:S0033-0620(26)00002.
    

    >> Share

    
    November 2025
20. BUENO G, Bot I, Kanhai AA, Stilhano R, et al
    Mast cells in cardiovascular disease: Fibrosis, angiogenesis and atherogenesis.
    Prog Cardiovasc Dis. 2025 Nov 23:S0033-0620(25)00170.
    

    >> Share

    
    
21. VOHRA S, Sakul S, Agarwal V, Patel KK, et al
    Quantification of myocardial blood flow using PET: Current status, clinical applications, and future directions.
    Prog Cardiovasc Dis. 2025;93:10-20.
    

    >> Share

    
    
22. ALWAN M, El Ghazawi A, El Yaman A, Al Rifai M, et al
    SPECT Myocardial Perfusion Imaging in the Era of PET and Multimodality Imaging: Challenges and Opportunities.
    Prog Cardiovasc Dis. 2025;93:3-9.
    

    >> Share

    
    
23. KNOTT JD, Kronzer E, Anavekar N, Chareonthaitawee P, et al
    Radionuclide imaging techniques for assessing myocardial viability: Clinical applications, evidence, and future directions.
    Prog Cardiovasc Dis. 2025;93:51-59.
    

    >> Share

    
    September 2025
24. POLO-LOPEZ A, Andersen LL, Nunez-Cortes R, Lopez-Bueno R, et al
    Handgrip strength asymmetry increases risk of all-cause and cardiovascular mortality: A dose-response analysis across 28 countries.
    Prog Cardiovasc Dis. 2025 Sep 30:S0033-0620(25)00146.
    

    >> Share

    
    
25. GERMAN CA, Petek BJ, Mongraw-Chaffin M
    The fit-fat index: Is it fitness or fatness or both that predicts sudden cardiovascular death?
    Prog Cardiovasc Dis. 2025 Sep 16:S0033-0620(25)00140.
    

    >> Share

    
    
26. EL YAMAN A, Alwan M, El Ghazawi A, Al-Mallah MH, et al
    Advances in nuclear hybrid imaging: The role of SPECT/CT, PET/CT, and PET/MRI in cardiovascular diseases.
    Prog Cardiovasc Dis. 2025 Sep 15:S0033-0620(25)00141.
    

    >> Share

    
    
27. JAISWAL V, Hanif M, Kumar D, Mashkoor Y, et al
    Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors along with colchicine versus colchicine alone among coronary artery disease and type 2 diabetes patients.
    Prog Cardiovasc Dis. 2025 Sep 2:S0033-0620(25)00132.
    

    >> Share

    
    
28. ISATH A, Panza JA
    Contemporary management of ischemic cardiomyopathy: The synergy of medical, revascularization, and device therapies.
    Prog Cardiovasc Dis. 2025;92:16-24.
    

    >> Share

    
    July 2025
29. MALICK WA, Al Dhaybi O, Bhatt DL
    Atherogenic dyslipidemia: A marker of cardiovascular risk in treated hypertension.
    Prog Cardiovasc Dis. 2025 Jul 23:S0033-0620(25)00107.
    

    >> Share

    
    
30. LEONE PP, Gitto M, Gao C, Sanchez JS, et al
    Rethinking coronary artery metal implants.
    Prog Cardiovasc Dis. 2025 Jul 17:S0033-0620(25)00104.
    

    >> Share

    
    
31. LOUBET P, Roubille F
    RSV in cardiovascular care: When the lungs speak to the heart.
    Prog Cardiovasc Dis. 2025 Jul 9:S0033-0620(25)00100.
    

    >> Share

    
    
32. PENDERS Y, Falsey AR, Bhatt DL, Bohm M, et al
    Burden and severity of respiratory syncytial virus infection in adults with cardiovascular diseases: A systematic literature review.
    Prog Cardiovasc Dis. 2025 Jul 2:S0033-0620(25)00088.
    

    >> Share

    
    June 2025
33. IMBODEN MT, Jones KG, Roth SE, Marsillo R, et al
    Treatment adherence patterns for patients with atherosclerotic cardiovascular disease: Patient and provider perspectives.
    Prog Cardiovasc Dis. 2025 Jun 22:S0033-0620(25)00082.
    

    >> Share

    
    
34. KHAN MS, Javaid SS, Mentz RJ, Lindenfeld J, et al
    Heart rate variability in patients with cardiovascular diseases.
    Prog Cardiovasc Dis. 2025 Jun 10:S0033-0620(25)00081.
    

    >> Share

    
    
35. PANTLIN PG, Bharwani S, Chung MK, Morin DP, et al
    Is it safe to use class 1C antiarrhythmic drugs in patients with coronary artery disease and/or cardiomyopathy?
    Prog Cardiovasc Dis. 2025 Jun 9:S0033-0620(25)00080.
    

    >> Share

    
    May 2025
36. KAZIBWE R, Jehopio J, Schaich CL, Rikhi R, et al
    Atherogenic dyslipidemia and incident cardiovascular events in high-risk hypertension.
    Prog Cardiovasc Dis. 2025 May 18:S0033-0620(25)00069.
    

    >> Share

    
    
37. KERMANSHAHCHI J, Kao AS, Ellberg CC, Duran E, et al
    First presentation of atherosclerotic cardiovascular disease in previously healthy individuals: The multi-ethnic study of atherosclerosis.
    Prog Cardiovasc Dis. 2025 May 14:S0033-0620(25)00075.
    

    >> Share

    
    
38. ROULEAU CR, Garland SN
    A social ecological perspective on interventions to address short sleep duration in adults with coronary heart disease.
    Prog Cardiovasc Dis. 2025 May 13:S0033-0620(25)00074.
    

    >> Share

    
    
39. TOTH PP, Banach M
    No second chances: Cardiovascular death is the most frequent incident event among patients with coronary artery calcium.
    Prog Cardiovasc Dis. 2025 May 13:S0033-0620(25)00073.
    

    >> Share

    
    
40. GOLUB IS, Misic A, Krishnan S, Hubbard L, et al
    CTA in roadmapping post-CABG evaluation.
    Prog Cardiovasc Dis. 2025;90:86-96.
    

    >> Share

    
    April 2025
41. LORENZATTI D, Motwani M
    Cardiovascular magnetic resonance in pulmonary hypertension: Keeping it simple.
    Prog Cardiovasc Dis. 2025 Apr 26:S0033-0620(25)00064.
    

    >> Share

    
    
42. KHAN MS, Rashid AM, Van Spall HGC, Greene SJ, et al
    Integrating cardiovascular implementation science research within healthcare systems.
    Prog Cardiovasc Dis. 2025 Apr 15:S0033-0620(25)00059.
    

    >> Share

    
    March 2025
43. FILTZ A, Gulati M
    Refining cardiovascular risk assessment: The interplay of lipoprotein (a) and waist-to-hip ratio.
    Prog Cardiovasc Dis. 2025 Mar 22:S0033-0620(25)00038.
    

    >> Share

    
    
44. SLIPCZUK L
    Assorted topics in cardiovascular disease 2025: Novel insights in prevention, diagnosis, and treatment.
    Prog Cardiovasc Dis. 2025 Mar 21:S0033-0620(25)00037.
    

    >> Share

    
    
45. SLIPCZUK L
    Continuing a legacy of excellence: A new chapter for Progress in cardiovascular diseases.
    Prog Cardiovasc Dis. 2025 Mar 21:S0033-0620(25)00039.
    

    >> Share

    
    
46. AHMAD MI, Chevli PA, Mirzai S, Rikhi R, et al
    Waist to hip ratio modifies the cardiovascular risk of lipoprotein (a): Insights from MESA.
    Prog Cardiovasc Dis. 2025 Mar 11:S0033-0620(25)00030.
    

    >> Share

    
    February 2025
47. LIPPI G, Lavie CJ, Gomar FS
    Unveiling the burden of acute myocardial infarction deaths associated with COVID-19 during the first five years of the pandemic.
    Prog Cardiovasc Dis. 2025 Feb 10:S0033-0620(25)00025.
    

    >> Share

    
    
48. CHAUNTRY AJ, Whittaker AC, Puterman E, Seeman T, et al
    Chronic psychological stress and cardiovascular disease risk: When to use single biomarkers versus allostatic load.
    Prog Cardiovasc Dis. 2025 Feb 8:S0033-0620(25)00026.
    

    >> Share

    
    January 2025
49. KIM DS, Schuetz N, Johnson A, Tolas A, et al
    Unlocking insights: Clinical associations from the largest 6-minute walk test collection via the my Heart Counts Cardiovascular Health Study, a fully digital smartphone platform.
    Prog Cardiovasc Dis. 2025 Jan 28:S0033-0620(25)00010.
    

    >> Share

    
    
50. CHATURVEDI A, Gadela NV, Kalra K, Chandrika P, et al
    Non-atherosclerotic coronary causes of myocardial infarction in women.
    Prog Cardiovasc Dis. 2025 Jan 27:S0033-0620(25)00008.
    

    >> Share

    
    
51. PATEL RAG, Brilakis ES
    Complex high-risk indicated percutaneous coronary intervention (CHIP): Introduction.
    Prog Cardiovasc Dis. 2025 Jan 22:S0033-0620(25)00006.
    

    >> Share

    
    
52. AL-OGAILI A, Gill GS, Brilakis ES
    Complications of percutaneous coronary intervention.
    Prog Cardiovasc Dis. 2025 Jan 7:S0033-0620(24)00174.
    

    >> Share

    
    
53. NEALY Z, Wang S, Patel AR
    The complex role of cardiovascular imaging in viability testing.
    Prog Cardiovasc Dis. 2025 Jan 7:S0033-0620(24)00177.
    

    >> Share

    
    
54. SHIN D, Galougahi KK, Singh M, Caron E, et al
    Coronary artery disease and percutaneous coronary intervention in patients with severe chronic kidney disease.
    Prog Cardiovasc Dis. 2025 Jan 4:S0033-0620(24)00173.
    

    >> Share

    
    
55. GUPTA A, Maitas O, Patel RAG
    Recurrent drug eluting stent, in-stent restenosis (DES-ISR): Epidemiology, pathophysiology & treatment.
    Prog Cardiovasc Dis. 2025 Jan 2:S0033-0620(24)00172.
    

    >> Share

    
    
56. BAGH I, Patel RAG
    Unprotected distal left main percutaneous intervention.
    Prog Cardiovasc Dis. 2025;88:53-59.
    

    >> Share

    
    
57. HYASAT K, Su CS, Kirtane AJ, McEntegart M, et al
    The efficacy of revascularization in ischemic cardiomyopathy.
    Prog Cardiovasc Dis. 2025;88:105-112.
    

    >> Share

    
    December 2024
58. ALLANA SS, Gondi K, Goyal A, Vallabhajosyula S, et al
    Retrograde approach to chronic total occlusion percutaneous coronary interventions- Technique and outcomes.
    Prog Cardiovasc Dis. 2024 Dec 30:S0033-0620(24)00171.
    

    >> Share

    
    
59. FRIZZELL J, Kereiakes DJ
    Calcified plaque modification during percutaneous coronary revascularization.
    Prog Cardiovasc Dis. 2024 Dec 9:S0033-0620(24)00170.
    

    >> Share

    
    November 2024
60. JAISWAL V, Hanif M, Mashkoor Y, Sawhney A, et al
    Cardiovascular outcomes among giant cell myocarditis compared with cardiac sarcoidosis: A propensity score-matched analysis.
    Prog Cardiovasc Dis. 2024 Nov 16:S0033-0620(24)00152.
    

    >> Share

    
    October 2024
61. LOPES KS, Junior AG, Fillmore N, da Silva Gomes R, et al
    Cardiovascular-kidney-metabolic syndrome - An integrative review.
    Prog Cardiovasc Dis. 2024 Oct 30:S0033-0620(24)00148.
    

    >> Share

    
    
62. BELMONTE M, Foa A, Paolisso P, Bergamaschi L, et al
    Coronary microvascular dysfunction beyond the spectrum of chronic coronary syndromes.
    Prog Cardiovasc Dis. 2024 Oct 22:S0033-0620(24)00142.
    

    >> Share

    
    
63. AL ZEIN M, Khazzeka A, El Khoury A, Al Zein J, et al
    Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?
    Prog Cardiovasc Dis. 2024 Oct 21:S0033-0620(24)00146.
    

    >> Share

    
    
64. AL JEBAJE Z, Jabri A, Mishra T, Halboni A, et al
    Use of mechanical circulatory support in high-risk percutaneous coronary interventions.
    Prog Cardiovasc Dis. 2024 Oct 21:S0033-0620(24)00143.
    

    >> Share

    
    
65. WANG XJ, Voortman T, de Crom TOE, Tilly M, et al
    Healthy and unhealthy plant-based diets and the risk of cardiovascular diseases: The Rotterdam study and updated meta-analysis.
    Prog Cardiovasc Dis. 2024 Oct 21:S0033-0620(24)00144.
    

    >> Share

    
    
66. RUNSEWE OI, Srivastava SK, Sharma S, Chaudhury P, et al
    Optical coherence tomography angiography in cardiovascular disease.
    Prog Cardiovasc Dis. 2024 Oct 21:S0033-0620(24)00145.
    

    >> Share

    
    
67. POLO-LOPEZ A, Calatayud J, Lopez-Bueno L, Nunez-Cortes R, et al
    Dose-response association of an accelerometer-measured physical activity with all-cause mortality and cardiovascular disease incidence: Prospective cohort with 76,074 participants.
    Prog Cardiovasc Dis. 2024 Oct 8:S0033-0620(24)00128.
    

    >> Share

    
    
68. UJJAWAL A, Lobo T, Yaggi HK, Neeland IJ, et al
    The connection between sleep deficiency and coronary artery disease: Complexities and controversies.
    Prog Cardiovasc Dis. 2024 Oct 7:S0033-0620(24)00126.
    

    >> Share

    
    September 2024
69. GAJAGOWNI S, Hopkins S, Qadeer Y, Virani SS, et al
    Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions.
    Prog Cardiovasc Dis. 2024 Sep 13:S0033-0620(24)00117.
    

    >> Share

    
    
70. POWER DA, Hemetsberger R, Farhan S, Abdel-Wahab M, et al
    Calcified coronary lesions: Imaging, prognosis, preparation and treatment state of the art review.
    Prog Cardiovasc Dis. 2024;86:26-37.
    

    >> Share

    
    August 2024
71. COLLET C, Amponsah DK, Mahendiran T, Mizukami T, et al
    Advancements and future perspectives in coronary angiography-derived fractional flow reserve.
    Prog Cardiovasc Dis. 2024 Aug 7:S0033-0620(24)00111.
    

    >> Share

    
    
72. LAVIE CJ
    Cardiovascular statistics 2024.
    Prog Cardiovasc Dis. 2024 Aug 5:S0033-0620(24)00103.
    

    >> Share

    
    July 2024
73. MASOOMI R, Moscardelli S, Hirai T, Azzalini L, et al
    Antegrade techniques for chronic total occlusion percutaneous coronary intervention.
    Prog Cardiovasc Dis. 2024 Jul 18:S0033-0620(24)00098.
    

    >> Share

    
    
74. KRISHNAN S, Aldana-Bitar J, Golub I, Kianoush S, et al
    Testosterone replacement therapy and cardiovascular risk: TRAVERSE with caution.
    Prog Cardiovasc Dis. 2024 Jul 17:S0033-0620(24)00100.
    

    >> Share

    
    June 2024
75. MONTONE RA, Ford T, Galli M, Rinaldi R, et al
    Stratified medicine for acute and chronic coronary syndromes: A patient-tailored approach.
    Prog Cardiovasc Dis. 2024 Jun 25:S0033-0620(24)00091.
    

    >> Share

    
    
76. ROZANSKI A, Gransar H, Park R, Miller RJH, et al
    The ethnic and racial diversity of patients undergoing coronary artery calcium scanning.
    Prog Cardiovasc Dis. 2024 Jun 24:S0033-0620(24)00093.
    

    >> Share

    
    
77. LOPEZ-BUENO R, Calatayud J, Del Pozo Cruz J, Yang L, et al
    Dose-response associations of the American Heart Association's new "Life's essential 8" metrics with all-cause and cardiovascular mortality in a nationally representative sample from the United States.
    Prog Cardiovasc Dis. 2024 Jun 24:S0033-0620(24)00090.
    

    >> Share

    
    
78. AROMIWURA AA, Cavalcante JL, Kwong RY, Ghazipour A, et al
    The role of artificial intelligence in cardiovascular magnetic resonance imaging.
    Prog Cardiovasc Dis. 2024 Jun 24:S0033-0620(24)00092.
    

    >> Share

    
    May 2024
79. SOROOSH GP, Tasdighi E, Adhikari R, Blaha MJ, et al
    Coronary artery calcium in 2023: Guidelines for LDL-C goals, non-statin therapies, and aspirin use.
    Prog Cardiovasc Dis. 2024 May 14:S0033-0620(24)00072.
    

    >> Share

    
    
80. MANUBOLU VS, Ichikawa K, Budoff MJ
    Innovations in cardiac computed tomography: Imaging in coronary artery disease.
    Prog Cardiovasc Dis. 2024 May 14:S0033-0620(24)00073.
    

    >> Share

    
    
81. GOMEZ S, Dudum R, Rodriguez F
    Inequities in atherosclerotic cardiovascular disease prevention.
    Prog Cardiovasc Dis. 2024 May 9:S0033-0620(24)00071.
    

    >> Share

    
    
82. GAMI A, Bisht S, Satish P, Blaha MJ, et al
    The utility of coronary artery calcium scoring to enhance cardiovascular risk assessment for South Asian adults.
    Prog Cardiovasc Dis. 2024 May 7:S0033-0620(24)00069.
    

    >> Share

    
    
83. SATISH P, Avenatti E, Patel J, Agarwala A, et al
    Understanding the spectrum of cardiovascular risk in women - A primer for prevention.
    Prog Cardiovasc Dis. 2024 May 4:S0033-0620(24)00070.
    

    >> Share

    
    
84. ALDANA-BITAR J, Golub IS, Moore J, Krishnan S, et al
    Colchicine and plaque: A focus on atherosclerosis imaging.
    Prog Cardiovasc Dis. 2024;84:68-75.
    

    >> Share

    
    April 2024
85. JAISWAL V, Sawhney A, Nebuwa C, Borra V, et al
    Association between testosterone replacement therapy and cardiovascular outcomes: A meta-analysis of 30 randomized controlled trials.
    Prog Cardiovasc Dis. 2024 Apr 5:S0033-0620(24)00055.
    

    >> Share

    
    March 2024
86. TUTOR A, O'Keefe EL, Lavie CJ, Elagizi A, et al
    Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases.
    Prog Cardiovasc Dis. 2024 Mar 26:S0033-0620(24)00054.
    

    >> Share

    
    
87. LAKSHMANAN S, Wei J, Cook-Wiens G, Pepine CJ, et al
    Comparison of risk profiles of participants in the Women's IschemiA TRial to reduce events in non-ObstRuctive CAD (WARRIOR) trial, using coronary computed tomography angiography vs invasive coronary angiography.
    Prog Cardiovasc Dis. 2024 Mar 26:S0033-0620(24)00053.
    

    >> Share

    
    
88. LIPPI G, Sanchis-Gomar F, Lavie CJ
    Excess mortality for acute myocardial infarction in the United States during the first two years of the COVID-19 pandemic.
    Prog Cardiovasc Dis. 2024 Mar 20:S0033-0620(24)00051.
    

    >> Share

    
    February 2024
89. KRISHNAN S, Aldana-Bitar J, Golub I, Ichikawa K, et al
    Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men.
    Prog Cardiovasc Dis. 2024 Feb 27:S0033-0620(24)00036.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share